Bone Marrow TransplantationTransplantation, HomologousBone MarrowBone Marrow CellsGraft vs Host DiseaseBone and BonesWhole-Body IrradiationLeukemiaRecurrenceTransplantation ChimeraTransplantation ConditioningAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraGraft vs Tumor EffectTissue DonorsLeukocyte TransfusionHematopoietic Stem Cell TransplantationBusulfanHematopoietic Stem CellsGraft SurvivalLeukemia, Myeloid, AcuteGraft vs Host ReactionPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibility TestingBone Marrow DiseasesGraft vs Leukemia EffectHematologic NeoplasmsLymphocyte DepletionMice, Inbred C57BLBone RemodelingRemission InductionBone Marrow ExaminationTransplantation, AutologousHistocompatibilityBone Marrow NeoplasmsT-LymphocytesAcute DiseaseBone Marrow PurgingHematopoiesisCyclophosphamideLeukemia, MyeloidLymphocyte TransfusionChimeraTransplantation, IsogeneicMyelodysplastic SyndromesTime FactorsMice, Inbred BALB CImmunosuppressive AgentsImmunosuppressionBone DensityTreatment OutcomeCombined Modality TherapySpleenNuclear FamilyCytomegalovirus InfectionsHepatic Veno-Occlusive DiseaseBone ResorptionSurvival AnalysisCyclosporineFlow CytometryColony-Forming Units AssayGraft RejectionTransplantation ImmunologyRetrospective StudiesHematologic DiseasesCell DifferentiationActuarial AnalysisFatal OutcomeBone NeoplasmsCells, CulturedNeoplasm, ResidualGranulocyte Colony-Stimulating FactorLymphocyte Culture Test, MixedMultiple MyelomaHLA AntigensSurvival RateSkin TransplantationImmunophenotypingCytarabinePancytopeniaAntigens, CD34Leukocyte CountMice, Inbred C3HIsoantigensMice, Inbred StrainsFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsAntigens, CDLymphoma, Non-HodgkinLymphocyte ActivationBone DevelopmentThymus GlandMethotrexateDisease-Free SurvivalLeukemia, Myelomonocytic, AcuteAntibodies, MonoclonalPrognosisMice, Inbred AKRCell Separation